PECAM1 and neoplasm: Immunostaining in tumor areas without prominent blood vessels showed that the number of CD31-positive vascular endothelial cells decreased as the tumor progressed (Figure 4e), consistent with the exacerbation of hypoxia during tumor progression [23].